Granutec Inc. / CRP Inc. / Barr Laboratories Inc. / AstraZeneca Pharmaceuticals LP / Nestle Co. / Deutsche Bank AG / Standard Oil Co. / Asahi Glass Co. / Barr Labs. / Novopharm Ltd. / U.S. Bancorp / Biovail Corp. / AstraZeneca PLC / Singer Mfg. / AstraZeneca UK Ltd. / Line Material Co. / Deering Milliken Inc. / Imperial Chemical Industries PLC / Andrx Pharm / Glens Falls Newspapers Inc. / Zeneca Ltd. / See Mova Pharm / Duplan Corp. / See Zeneca Ltd. / Flex-Foot Inc. / Windmere Corp. / Heumann Pharma GmbH & Co. / Zeneca Inc. / Schering-Plough Corp. / Valley Drug Co. / Kroger Co. / Rohm & Haas Co. / U.S. Philips Corp. / Pharmachemie B.V. / Mylan Pharmaceuticals Inc. / /
Country
United States / /
Currency
USD / pence / /
Event
FDA Phase / Legal Issues / M&A / Business Partnership / /
Facility
United States District Court / /
IndustryTerm
drug manufacturer / generic manufacturer / federal patent law / treatment of breast cancer / defendant generic manufacturer / generic marketer / intellectual property law / antitrust law / raw material supplier / long-settled law / patent law / unbranded version / state-law claims / /
Organization
United States District Court for the Southern District of New York / Patent and Trademark Office / Supreme Court / United States Court of Appeals / United States Food and Drug Administration / US Federal Reserve / United States District Court for the District of Maryland / United States District Court for the Eastern District of New York / F.T.C. / Congress / UN Court / United States District Court for the District / /
Person
I. Leo Glasser / Daniel A. Crane / Maureen A. O'Rourke / Sherman Act / Vincent L. Broderick / Dawson Chem / Joseph F. Brodley / /
In Re: Tamoxifen Citrate Antitrust Litigation UNITED STATES COURT OF APPEALS FOR THE SECOND CIRCUIT 466 F.3d 187 August 10, 2006, Decided [*190]